Loading...
  • 25mg
  • Other medications (eg order dipyridamole 25mg on-line heart attack young square, a cor- of accumulation to toxic levels and additional renal ticosteroid, methotrexate, a nonsteroidal anti-inflammatory damage. (pili.org)
  • Pathways
  • We suggest that when used at appropriate doses and with the correct mode of administration, dipyridamole is a promising agent for breast-cancer treatment, thus also implying its potential use in other cancers that show those highly activated pathways. (springer.com)
  • reduces
  • Experimental metastasis assays show dipyridamole reduces metastasis formation by 47.5 % in the MDA-MB-231T xenograft model ( p = 0.0122), and by 50.26 % in the 4T1-Luc xenograft model ( p = 0.0292). (springer.com)
  • The investigators hypothesize that dipyridamole reduces the gastrointestinal absorption of metformin. (clinicaltrials.gov)
  • vascular
  • However, it is not licensed as monotherapy for stroke prophylaxis, although a Cochrane Review suggested that dipyridamole may reduce the risk of further vascular events in patients presenting after cerebral ischemia. (wikipedia.org)
  • stroke
  • The antihyperglycemic drug metformin and the thrombocyte aggregation inhibitor dipyridamole are often used concomitantly in patients with diabetes who have suffered a transient ischemic attack or stroke. (clinicaltrials.gov)
  • In contrast, addition of dipyridamole (DP) to ASA in the European Stroke Prevention Study (ESPS)-2 and the European/Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) reduced the RR of stroke by about 20% compared with ASA alone, without incurring excess bleeding. (ahajournals.org)
  • ischemic
  • Dipyridamole is a widely prescribed drug in ischemic disorders, and it is here investigated for potential clinical use as a new treatment for breast cancer. (springer.com)
  • uses
  • Dipyridamole also has non-medicinal uses in a laboratory context, such as the inhibition of cardiovirus growth in cell culture. (wikipedia.org)
  • treatment
  • Treatment with 15 mg/kg/day dipyridamole reduced mean primary tumor size by 67.5 % ( p = 0.0433), while treatment with 30 mg/kg/day dipyridamole resulted in an almost a total reduction in primary tumors ( p = 0.0182). (springer.com)